Blue Crest Capital Management LTD Aldeyra Therapeutics, Inc. Transaction History

Blue Crest Capital Management LTD

  • $1.62 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$7.26 - $13.29 $145,200 - $265,800
-20,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$6.8 - $14.35 $136,000 - $287,000
20,000 New
20,000 $276,000
Q2 2018

Aug 14, 2018
SELL
$6.95 - $9.18 $99,878 - $131,925
-14,371 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$6.55 - $8.9 $94,130 - $127,901
14,371 New
14,371 $108,000

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $280M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email